0001838271-21-000002.txt : 20210106 0001838271-21-000002.hdr.sgml : 20210106 20210106165838 ACCESSION NUMBER: 0001838271-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20210106 DATE AS OF CHANGE: 20210106 EFFECTIVENESS DATE: 20210106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pandemic Innovation Fund, L.P. CENTRAL INDEX KEY: 0001838271 IRS NUMBER: 853964953 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-385431 FILM NUMBER: 21511414 BUSINESS ADDRESS: STREET 1: 1100 CORPORATE SQUARE DR STREET 2: SUITE 227 CITY: SAINT LOUIS STATE: MO ZIP: 63132 BUSINESS PHONE: 314-216-2051 MAIL ADDRESS: STREET 1: 911 WASHINGTON AVENUE STREET 2: SUITE 801 CITY: SAINT LOUIS STATE: MO ZIP: 63101 D 1 primary_doc.xml X0708 D LIVE 0001838271 Pandemic Innovation Fund, L.P. 1100 Corporate Square Dr Suite 227 Saint Louis MO MISSOURI 63132 314-216-2051 DELAWARE None None Limited Partnership true 2020 - Cultivation Capital, LLC 1100 Corporate Square Dr Suite 227 Saint Louis MO MISSOURI 63132 Promoter The Issuer's management company. - HealthX Management, LLC 316 W. Washington Ave Suite 925 Madison WI WISCONSIN 53703 Promoter The Issuer's sub-manager. - Pandemic Innovation GP, LLC 1100 Corporate Square Dr Suite 227 Saint Louis MO MISSOURI 63132 Director Promoter The Issuer's general partner. William Raymond Schmidt 1100 Corporate Square Dr Suite 227 Saint Louis MO MISSOURI 63132 Director Promoter Managing director of the Issuer. Elise Miller Hoffman 1100 Corporate Square Dr Suite 227 Saint Louis MO MISSOURI 63132 Director Promoter Managing director of the Issuer. Mark Edmond Bakken 316 W. Washington Ave Suite 925 Madison WI WISCONSIN 53703 Director Promoter Managing director of the Issuer. Taha Yasin Jangda 316 W. Washington Ave Suite 925 Madison WI WISCONSIN 53703 Director Promoter Managing director of the Issuer. Pooled Investment Fund Venture Capital Fund false Not Applicable 06b 3C 3C.1 false 2020-12-23 true true false 250000 25000000 6060000 18940000 The Issuer is offering $25 million but has reserved the right to offer up to $50 million. false 13 0 0 0 true The Issuer's general partner is entitled to carried interest and the investment manager is entitled to a management fee. The carried interest and management fee are fully disclosed in the Issuer's confidential offering materials. false Pandemic Innovation Fund, L.P. William R. Schmidt William R. Schmidt Managing Director 2021-01-06